Gao, Yonglin
Mack, Aaron A.
Litteral, Carleigh
Delamere, Nicholas A.
El-Mallakh, Rif S.
Funding for this research was provided by:
Jesse H. Wright, M.D. Endowment for Mood Disorders Research (no number, no number)
Article History
Received: 30 November 2021
Accepted: 2 June 2022
First Online: 21 June 2022
Competing interests
: Dr. El-Mallakh is a speaker for the following pharmaceutical companies: Eisai, Indivior, Intra-Cellular, Janssen, Lundbeck, Otsuka, Sunovion, and Teva. None of the other authors have any potential conflicts of interest.